A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica - Top-Institutions - MDSpire

A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica

  • By

  • Edoardo Conticini

  • Raffaele Truscelli

  • Silvia Grazzini

  • Paolo Falsetti

  • Caterina Baldi

  • Alessandra Cartocci

  • Luca Cantarini

  • Bruno Frediani

  • February 26, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Immunology
    • Clinical Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Vascular Medicine
    • Clinical Immunology

  • #3

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Rheumatology
    • Clinical Trials
    • Immunology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Rheumatology
    • Clinical Research
    • Immunology

Original Source(s)

A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica

  • by Edoardo Conticini, Raffaele Truscelli, Silvia Grazzini, Paolo Falsetti, Caterina Baldi, Alessandra Cartocci, Luca Cantarini, Bruno Frediani

  • February 26, 2026

Related Content

A machine learning-based classification model for interstitial lung disease in rheumatoid arthritis

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

PR Flares Linked to Future Arthritis Sites

Persistent arthritis often develops in joints affected during earlier flares